journal article·2022-09

Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia

Gang Zhong, Huiping Long, Tian Zhou, Yisi Liu, Jianping Zhao, Jinyu Han, Xiaohu Yang, Yin Yu, Fei Chen, Shengliang Shi

Biomaterials· Volume 288
Publisher page

Abstract

Current treatments for Alzheimer's disease (AD) that focus on inhibition of Aβ aggregation failed to show effectiveness in people who already had Alzheimer's symptoms. Strategies that synergistically exert neuroprotection and alleviation of oxidative stress could be a promising approach to correct the pathological brain microenvironment. Based on the key roles of microglia in modulation of AD microenvironment, we describe here the development of Prussian blue/polyamidoamine (PAMAM) dendrimer/Angiopep-2 (PPA) nanoparticles that can regulate the mitophagy of microglia as a potential AD treatment. PPA nanoparticles exhibit superior blood-brain barrier (BBB) permeability and exert synergistic effects of ROS scavenging and restoration of mitochondrial function of microglia. PPA nanoparticles effectively reduce neurotoxic Aβ aggregate and rescue the cognitive functions in APP/PS1 model mice. Together, our data suggest that these multifunctional dendrimer nanoparticles exhibit efficient neuroprotection and microglia modulation and can be exploited as a promising approach for the treatment of AD.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Neuroinflammation and Neurodegeneration Mechanisms · Alzheimer's disease research and treatments · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. Alzheimer's disease facts and figures10.1016/j.jalz.2016.03.001 ↗
2. Plasma levels of complement 4a protein are increased in Alzheimer's disease10.1097/WAD.0b013e318239dcbd ↗
3. Alzheimer's disease: a cell biological perspective10.1126/science.256.5058.780 ↗
4. Microglia influence host defense, disease, and repair following murine coronavirus infection of the central nervous system10.1002/glia.23844 ↗
5. Ameboid microglia as effectors of inflammation in the central nervous system10.1002/jnr.490180123 ↗
6. Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases10.1126/science.abb8587 ↗
7. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?10.1038/s41582-020-00435-y ↗
8. Mitochondrial dysfunction and alzheimer's disease: role of microglia10.3389/fnagi.2020.00252 ↗
9. N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease10.1038/s41467-020-16080-4 ↗
10. Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation10.1111/jpi.12667 ↗
11. Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers10.1021/jacs.5b12070 ↗
12. Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model10.1016/j.jconrel.2018.06.003 ↗
13. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-210.1111/j.1471-4159.2008.05492.x ↗
14. Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting10.1021/jm2014919 ↗
15. Targeting Alzheimer's disease with multimodal polypeptide-based nanoconjugates10.1126/sciadv.abf9180 ↗
16. Intelligent nanocomposites with intrinsic blood-brain-barrier crossing ability designed for highly specific MR imaging and sonodynamic therapy of glioblastoma10.1002/smll.201906985 ↗
17. Apolipoprotein e Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma10.1021/acsnano.8b05265 ↗
18. Sensitivity of susceptibility-weighted imaging in detecting superparamagnetic iron oxide-labeled mesenchymal stem cells: a comparative study10.5812/iranjradiol.20782 ↗
19. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease10.1006/mcne.2001.1016 ↗
20. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease10.1523/JNEUROSCI.22-05-01858.2002 ↗
21. Cell membrane camouflaged hollow prussian blue nanoparticles for synergistic photothermal-/chemotherapy of cancer
22. TREM2 maintains microglial metabolic fitness in alzheimer's disease10.1016/j.cell.2017.07.023 ↗
23. Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region10.15252/emmm.201911227 ↗
24. Microglia use TAM receptors to detect and engulf amyloid β plaques10.1038/s41590-021-00913-5 ↗
25. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline10.1038/s41586-018-0543-y ↗
26. The blood-brain barrier in Alzheimer's disease10.1016/j.nbd.2016.07.007 ↗
27. The dynamic blood-brain barrier10.1111/febs.13412 ↗
28. Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity10.1038/nature25143 ↗
29. Visualizing and modulating mitophagy for therapeutic studies of neurodegeneration10.1016/j.cell.2020.04.025 ↗
30. Ageing as a risk factor for neurodegenerative disease10.1038/s41582-019-0244-7 ↗
31. Microglia in neurodegeneration10.1038/s41593-018-0242-x ↗
32. Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells10.1074/jbc.272.46.29390 ↗
33. Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease10.1186/1750-1326-6-45 ↗
34. Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease10.1038/nature25158 ↗
35. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease
36. Iba1 is an actin-cross-linking protein in macrophages/microglia10.1006/bbrc.2001.5388 ↗
37. Memory loss in alzheimer's disease10.31887/DCNS.2013.15.4/hjahn ↗
38. Microglia dysfunction caused by the loss of rhoa disrupts neuronal physiology and leads to neurodegeneration10.1016/j.celrep.2020.107796 ↗
39. Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease10.1016/S0304-3940(02)00888-1 ↗
40. Microglia as a potential bridge between the amyloid beta-peptide and tau10.1196/annals.1332.006 ↗
41. Iron oxide nanoparticles promote macrophage autophagy and inflammatory response through activation of toll-like Receptor-4 signaling10.1016/j.biomaterials.2019.02.026 ↗
42. Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease10.1007/s00259-018-4032-1 ↗
43. Mitochondrial membrane potential10.1016/j.ab.2017.07.009 ↗
44. Cellular and molecular mechanisms of mitochondrial function10.1016/j.beem.2012.05.003 ↗